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ABSTRACT
A successful pregnancy was established in a functionally agonadal woman using oocyte dona-
tion following resection of a large leiomyoma. The patient had a 6 \m=x\6 cm intramural tumor
with intracavitary extension. She was symptomatic with metrorrhagia. A conservative ap-
proach was undertaken in an attempt to restore normal endometrial anatomy. Hysteroscopic
resection removed a 3 \m=x\3 \m=x\2 cm mass. Postoperatively, hysteroscopy was normal, and oocyte
donation was performed. Implantation occurred, and a living, 3600 g female infant was deliv-
ered vaginally at 40 weeks gestation without complication. This case illustrates an approach to
managing cavity-distorting leiomyomas in perimenopausal women interested in oocyte dona-
tion. When hysteroscopic resection of leiomyomas is successful, major surgery is avoided, and
pregnancy, labor, and deliverymay proceed normally. (J GYNECOL SURG 10:255, 1994)
INTRODUCTION
OOCYTE donation has become the treatment of choice for infertile perimenopausal women who are at-tempting pregnancy.1-3 Patients with elevated serum gonadotropins have limited success using any of the
other assisted reproductive methods.4 Published criteria for accepting patients into an oocyte donation pro-
gram generally have required demonstration of a normal intrauterine cavity, defined either by hysterosalpin-
gogram (HSG) or hysteroscopy.23
We have reported good success rates for both embryo implantation and delivery in women undergoing
oocyte donation who are known to have asymptomatic leiomyomas without submucosal extension.5 In our ex-
perience, priormyomectomy has not improved results in terms of obstetric outcome. However, women choos-
ing not to undergo myomectomy have experienced a significantly greater incidence of pelvic pain during the
first trimester. We report a patientwith a largemyoma with intramural and submucosal components who chose
hysteroscopic resection instead of laparotomy and myomectomy before undergoing assisted reproduction.
CASE REPORT
The patient is a 45-year-old white nulligravida with primary infertility for 10 years. During the past 4 years,
she experienced three unsuccessful attempts at in vitro fertilization. Recently, a leiomyomatous uterus was dis-
covered following an evaluation for intermenstrual bleeding. Hermenstrual periods were irregular, with inter-
vals of 45-60 days. The patient had elevated day 3 serum follicle-stimulating hormone (FSH) levels varying
between 30 and 40mlU/mL. Transvaginal ultrasound revealed an enlarged uterus with an approximately 6x6
cm posterior-intramural leiomyoma with a submucosal component. Two other 3 cm leiomyomas were noted
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laterally. The endometrial echo was noted to be contiguous with the largest tumor. An HSG demonstrated ex-
tension of the mass into the endometrial cavity (Fig. 1). Office hysteroscopy confirmed an approximately 3 x
3 x 2 cm intracavitary component. This represented approximately 40% of the tumor volume.
The patient was advised of the possible implications of a symptomatic submucosal leiomyoma. Concerns
included the tumor's effect on implantation and the possibility for unscheduled bleeding, which might have a
negative effect on implantation and early embryonic development. Furthermore, pregnancy might be compli-
cated by large leiomyomas disrupting normal placentation and fetal development, as well as increasing the
risks of both preterm labor and birth.
We discussed three treatment options: (1) proceeding without surgery, (2) undergoing laparotomy and my-
omectomy, and (3) undergoing hysteroscopic resection of the mass to restore a normal endometrial cavity. If
abnormal bleeding could be ameliorated, the plan was to proceed with embryo transfer. The patient elected the
last option and was scheduled for outpatient surgery.
Before undergoing surgery, the patient received gonadotropin-releasing hormone (GnRH) agonist for 60
days in hopes of improving intrauterine visualization and shrinking the myoma. However, only minimal de-
crease in tumor size occurred, and intermittent bleeding persisted. Under general anesthesia, the patient under-
went resection using a 27F continuous flow gynecologic resectoscope with 1.5% glycine as a uterus-distend-
ing medium. The tumor was progressively shaved down to its base.
The patient did well postoperatively and was placed on a standard regimen of sequential oral micronized
estradiol (2 mg) andmedroxyprogesterone acetate (5 mg) for 2 months, and normal withdrawal bleedings fol-
lowed. Hysteroscopy was performed, and the cavity was normal. An endometrial biopsy while on hormone re-
placement therapy demonstrated a normal secretory response.
Oocyte donation was performed, and gametes were provided by a 30-year-old fertile donor. Five preem-
bryos were transferred transcervically, as described previously.2 Beta-hCG levels were increased 9 days after
transfer, and ultrasound examination approximately 2 weeks later showed a single intrauterine gestational sac.
The pregnancy was supported with estradiol and progesterone. The patient experienced no pelvic pain, and the
leiomyoma maintained its size at approximately 4 x 4 cm (Fig. 2). Hormones were discontinued by the 14th
week of gestation, when serum levels of progesterone were above 50 ng/mL.
The second and third trimesters were uncomplicated, and labor was induced at 40 weeks gestational age.
The patient delivered a living, 3600 g female infant. The placenta was delivered without complications and
found to be of normal size, weight, and contour. The patient did well and experienced minimal postpartum
bleeding.
FIG. 1. Hysterosalpingogram performed before hysteroscopic resection showed the presence of a large intracavitary
leiomyoma.
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FIG. 2. The 4 x 4 cm leiomyoma that remained unresected was visible on transvaginal ultrasound adjacent to the early
pregnancy implantation site.
DISCUSSION
Oocyte donation has become increasingly popular for treating infertile women 40-50 years of age. This
method provides older infertile individuals the best opportunity for pregnancy. Recommendations have been
to extend therapy only to patients with a normal endometrial cavity. This maximizes pregnancy potential by
eliminating an adverse endometrial environment. In our experience, leiomyomas have been present in 25% of
our oocyte donation patients. No decrease in overall embryo implantation or pregnancy rates was noted among
asymptomatic patients withmyomas if their uterine cavities were normal. However, women with leiomyomas
in situ were significantly more likely to complain of pelvic pain during the first and second trimesters.
Hysteroscopic resection of leiomyomas has been advocated for treating symptomatic submucosal myomas.6
The role of hysteroscopic resection before pregnancy attempts remains undefined, although successful preg-
nancies have been reported.6 In patients experiencing abnormal uterine bleeding, it is probable that embryo
transfer is adversely affected by bleeding. Endometrial shedding may increase the likelihood of washing out
the free-floating embryo. Exposure to large numbers of white blood cells also might increase the probability
that the zygote would be phagocytized.
This patient continued to bleed irregularly, and intracavitary extension of the lesion persisted despite GnRH
agonist therapy. Therefore, surgery was recommended. Certainly, hysteroscopic resection has the advantage
ofbeing less morbid because there is no abdominal incision, blood loss is less, and it is an outpatient procedure.
Understanding that the chance of success with embryo donation was approximately 35% per embryo transfer,
the patient elected to take the most conservative approach.
This case represents the first report of a perimenopausal woman attempting pregnancy following a hystero-
scopically resected submucosal leiomyoma and oocyte donation. It demonstrates the ability to reestablish a
normal endometrial cavity capable of sustaining a pregnancy. However, more cases ofhysteroscopic resection
before embryo donation are needed to better define the value of this unique treatment regimen.
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